About Phathom Pharma (PHAT)
Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing treatments for gastrointestinal (GI) diseases. Its product candidate, vonoprazan, is an oral small molecule pot... Read more
- USD15.05
- USD15.32
- USD14.87
- USD16.08
- 9.50%
- 147M
- 446.08k
- 1.00M
- 1.1B
- 2.21
- 58.70%
Stock News
yesterday
Students pursuing these 11 degrees will be eligible to take out up to $200,000 in federal loans under new borrowing limits
CNBC
yesterday
Economy muddled along during the shutdown, the Fed found. Is another rate cut on tap?
MarketWatch
yesterday
A Hearty Helping for the Holidays: Republic Services Distributes 1,000 Turkeys Across Tennessee
Yahoo
yesterday
Workday shares sink on subscription revenue guidance concerns
CNBC